Assenagon Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.1M | Buy |
1,039,484
+230,362
| +28% | +$12.7M | 0.08% | 177 |
|
|
2025
Q1 | $57.2M | Buy |
809,122
+197,455
| +32% | +$14M | 0.1% | 175 |
|
|
2024
Q4 | $40.2M | Buy |
611,667
+502,695
| +461% | +$33M | 0.06% | 220 |
|
|
2024
Q3 | $7.66M | Sell |
108,972
-243,502
| -69% | -$17.1M | 0.01% | 570 |
|
|
2024
Q2 | $29M | Buy |
352,474
+349,329
| +11,107% | +$28.8M | 0.06% | 204 |
|
|
2024
Q1 | $275K | Sell |
3,145
-13,842
| -81% | -$1.21M | ﹤0.01% | 1267 |
|
|
2023
Q4 | $1.64M | Sell |
16,987
-86,091
| -84% | -$8.3M | ﹤0.01% | 962 |
|
|
2023
Q3 | $9.12M | Sell |
103,078
-186,122
| -64% | -$16.5M | 0.03% | 380 |
|
|
2023
Q2 | $25.1M | Sell |
289,200
-79,548
| -22% | -$6.9M | 0.09% | 172 |
|
|
2023
Q1 | $35.9M | Sell |
368,748
-336,000
| -48% | -$32.7M | 0.13% | 135 |
|
|
2022
Q4 | $72.9M | Buy |
704,748
+313,566
| +80% | +$32.5M | 0.26% | 72 |
|
|
2022
Q3 | $33.2M | Buy |
391,182
+151,946
| +64% | +$12.9M | 0.13% | 140 |
|
|
2022
Q2 | $19.8M | Buy |
239,236
+188,671
| +373% | +$15.6M | 0.07% | 214 |
|
|
2022
Q1 | $3.9M | Sell |
50,565
-68,115
| -57% | -$5.25M | 0.01% | 568 |
|
|
2021
Q4 | $10.5M | Buy |
118,680
+104,127
| +716% | +$9.2M | 0.03% | 295 |
|
|
2021
Q3 | $1.13M | Buy |
+14,553
| New | +$1.13M | ﹤0.01% | 830 |
|
|
2020
Q4 | – | Sell |
-7,111
| Closed | -$541K | – | 987 |
|
|
2020
Q3 | $541K | Sell |
7,111
-13,865
| -66% | -$1.05M | ﹤0.01% | 919 |
|
|
2020
Q2 | $2.59M | Buy |
20,976
+6,787
| +48% | +$837K | 0.02% | 499 |
|
|
2020
Q1 | $1.2M | Buy |
+14,189
| New | +$1.2M | 0.01% | 454 |
|
|
2018
Q2 | – | Sell |
-3,690
| Closed | -$299K | – | 419 |
|
|
2018
Q1 | $299K | Sell |
3,690
-696
| -16% | -$56.4K | ﹤0.01% | 463 |
|
|
2017
Q4 | $391K | Buy |
+4,386
| New | +$391K | ﹤0.01% | 569 |
|
|
2017
Q2 | – | Sell |
-3,680
| Closed | -$323K | – | 181 |
|
|
2017
Q1 | $323K | Buy |
+3,680
| New | +$323K | 0.01% | 160 |
|